IP Library › Granted Patent US 7,638,604
Granted Patent B2
US 7,638,604 · App. 10/873,972 · Granted Dec 29, 2009

Monoclonal antibodies against interleukin-22

Assignee: Genetics Institute, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,638,604
App. No.
10/873,972
Granted
Dec 29, 2009
Kind
B2
Abstract

Antibodies and antigen-binding fragments thereof that bind interleukin-22 (IL-22), in particular, human IL-22, and their uses in regulating IL-22-associated immune responses are disclosed. The antibodies disclosed herein are useful in diagnosing, preventing, or treating IL-22-associated immune disorders, e.g., autoimmune disorders (e.g., arthritis).

Claims (1)

1. A monoclonal antibody produced by a hybridoma chosen from PTA-5254 and PTA-5255.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2004
From: LI, JING; TAN, XIANG-YANG; TOMKINSON, KATHLEEN N.; PITTMAN, DEBRA D.; VELDMAN, GEERTRUIDA M.; FOUSER, LYNETTE
To: GENETICS INSTITUTE, LLC
Reel/Frame 015255/0743 →
Continuity (5)
Continuation In Part 1008429800 · Feb 25, 2002
Provisional Application 6048065200 · Jun 23, 2003
Provisional Application 6027082300 · Feb 23, 2001
Provisional Application 6028135300 · Apr 3, 2001
Related Publication 20050042220A1 · Feb 24, 2005